<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EEAE6F71-581F-4698-B110-C781202A2094"><gtr:id>EEAE6F71-581F-4698-B110-C781202A2094</gtr:id><gtr:firstName>Sebastien</gtr:firstName><gtr:surname>Gagneux</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U117588500"><gtr:id>D2985530-AD28-454D-961B-805E9B11FB32</gtr:id><gtr:title>The nature and consequence of genetic diversity in Mycobacterium tuberculosis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U117588500</gtr:grantReference><gtr:abstractText>The bacteria that cause human tuberculosis occur worldwide. However, different tuberculosis bacteria predominate in different parts of the world. Does this mean we need separate vaccines for Asia, Africa, America, and Europe?||We are trying to address this question by i) comparing the genome sequences of tuberculosis bacteria from different countries, and ii) by studying how the host immune system recognises these different bacteria.||Drug-resistant tuberculosis is also becoming an increasing problem in many parts of the world. Because no new tuberculosis drugs have been developed for decades, resistance to the current drugs has the potential to render tuberculosis incurable.||We are studying how bacterial diversity influences the emergence of drug-resistant tuberculosis. This will help extend the lifespan of the current drugs as well as help inform the development of new tools to better control tuberculosis.</gtr:abstractText><gtr:technicalSummary>Tuberculosis remains a global public health problem. The worldwide emergence of drug-resistant strains of Mycobacterium tuberculosis is threatening to make tuberculosis, which is already one of the most important infectious diseases untreatable. There is mounting evidence that genetic variation in M. tuberculosis is larger than previously thought. However, whether this diversity has any significant impact on pathogenesis or disease transmission remains unclear. The overall aim of this research programme is to characterise the genetic diversity of M. tuberculosis, to study the evolutionary forces shaping this diversity, and to evaluate the phenotypic effects of strain diversity. The specific research objectives are i) to determine the global genetic population structure of M. tuberculosis, ii) to determine the role of random genetic drift and migration (as opposed to natural selection) in the evolution of M. tuberculosis, iii) to study the impact of compensatory evolution on the competitive fitness and transmission of drug-resistant M. tuberculosis, and iv) to investigate the influence of strain variation on the host innate immune response.||Our overall approach is to integrate population genetic and ecological approaches and concepts with experimental and molecular epidemiological studies. To define the global population structure of M. tuberculosis, and to study the evolutionary forces shaping strain diversity, we are developing collaborative links with various research institutions in tuberculosis endemic countries of Africa, Asia, and Latin-America. These collaborators are providing representative mycobacterial strains and associated epidemiological data. These strains are then subjected to high-throughput genome sequencing or single-nucleotide-polymorphism (SNP) typing in collaboration with the Broad Institute and the Wellcome Trust Sanger Institute. To evaluate the effect of strain diversity on the bacterial fitness and host immune signalling, we perform infection experiments in macrophages and mice. To confirm the phenotypic role of particular genetic variants, defined mutants are constructed in the laboratory and tested using in vitro and in vivo assays. Finally, the population genomic and experimental data are correlated with detailed molecular epidemiological data from various clinical settings. We anticipate that this research programme will generate important new insights into the role of strain diversity in the host-pathogen interaction and in the emergence of drug resistance. A better understanding of these issues is crucial for the successful development and deployment of new tools and tactics to control tuberculosis.</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1053346</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>61295</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>University of California</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>University of California</gtr:fundingOrg><gtr:id>712D5B58-7BD3-4165-8978-1A207E104179</gtr:id><gtr:outcomeId>C85AFE352AD0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>149000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Leverhulme-Royal Society Africa Award R1-2009</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>AC0B9115-BC9A-4E49-82EA-2ECD77578167</gtr:id><gtr:outcomeId>36F25DD56F20</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>57126</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Case Western University Research Grant-2007</gtr:description><gtr:end>2010-04-02</gtr:end><gtr:fundingOrg>Case Western Reserve University</gtr:fundingOrg><gtr:id>6225C071-7D4A-4537-AC3D-F3B3DEA9402F</gtr:id><gtr:outcomeId>EFE05963A650</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A567309D-B838-48DD-AEED-22B25802BAEF</gtr:id><gtr:title>A role for systems epidemiology in tuberculosis research.</gtr:title><gtr:parentPublicationTitle>Trends in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ffdef5db9718e542bc9c7fecadbae6d"><gtr:id>1ffdef5db9718e542bc9c7fecadbae6d</gtr:id><gtr:otherNames>Comas I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0966-842X</gtr:issn><gtr:outcomeId>rojPRWUfrNZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>940160F7-58AD-40CA-9A1B-C52D1275F45C</gtr:id><gtr:title>Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad24357326ec53a8a8f6a94520c6163c"><gtr:id>ad24357326ec53a8a8f6a94520c6163c</gtr:id><gtr:otherNames>Nahid P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>ARsECfgkCxe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DECA5D01-0A63-4961-B3CA-275A5D2FE629</gtr:id><gtr:title>Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprints.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe50acfe7199cc155051e4717ed75612"><gtr:id>fe50acfe7199cc155051e4717ed75612</gtr:id><gtr:otherNames>Niemann S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>F5FCE94DD40</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EE4867C-9E13-4D5D-973B-67C235B65E5D</gtr:id><gtr:title>Fitness cost of drug resistance in Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17a182fb969f0ef4bdd01e29e7fbb827"><gtr:id>17a182fb969f0ef4bdd01e29e7fbb827</gtr:id><gtr:otherNames>Gagneux S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1198-743X</gtr:issn><gtr:outcomeId>A863F1C3393</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6445C127-99B8-4431-A909-AF98FC1B66FE</gtr:id><gtr:title>Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac19822f6c0ab65e3e7ca949b128e9ae"><gtr:id>ac19822f6c0ab65e3e7ca949b128e9ae</gtr:id><gtr:otherNames>Borrell S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1027-3719</gtr:issn><gtr:outcomeId>8050F278886</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE44CB4C-4DA4-46CF-B530-CF6587B2C25E</gtr:id><gtr:title>Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c9202ecb75df074fbc73bcb36cf26ad"><gtr:id>8c9202ecb75df074fbc73bcb36cf26ad</gtr:id><gtr:otherNames>Portevin D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>hKsuQK89ZYB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41495D8D-259B-4C3B-8F29-EAB63EF2B1AF</gtr:id><gtr:title>Use of spoligotyping and large sequence polymorphisms to study the population structure of the Mycobacterium tuberculosis complex in a cohort study of consecutive smear-positive tuberculosis cases in The Gambia.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32e2c5e83ca8d1853991693161a6184d"><gtr:id>32e2c5e83ca8d1853991693161a6184d</gtr:id><gtr:otherNames>de Jong BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>6689FE73341</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF82F2C0-D64D-4699-ABE0-F25DDCFCF0D3</gtr:id><gtr:title>Mycobacterium africanum--review of an important cause of human tuberculosis in West Africa.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32e2c5e83ca8d1853991693161a6184d"><gtr:id>32e2c5e83ca8d1853991693161a6184d</gtr:id><gtr:otherNames>de Jong BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>sNVuwDr4jKz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E56D6CD-0A6D-4F37-A2CB-B683C9195166</gtr:id><gtr:title>Relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40ec8f62afb1d137644703209732a96e"><gtr:id>40ec8f62afb1d137644703209732a96e</gtr:id><gtr:otherNames>Thwaites G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>F7C091D368A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5651068E-B9D6-4A16-B979-C94F5431F63D</gtr:id><gtr:title>Prevalence of fluoroquinolone resistance among tuberculosis patients in Shanghai, China.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39fec97586c55d71fbf0fd10e915c622"><gtr:id>39fec97586c55d71fbf0fd10e915c622</gtr:id><gtr:otherNames>Xu P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>C26E9C628C4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89344A7B-356F-4A7F-80E7-5D3F50483825</gtr:id><gtr:title>Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ffdef5db9718e542bc9c7fecadbae6d"><gtr:id>1ffdef5db9718e542bc9c7fecadbae6d</gtr:id><gtr:otherNames>Comas I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>CReAnvnbtQP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACF902C0-5207-4B83-BB2E-E29D0D22841C</gtr:id><gtr:title>The past and future of tuberculosis research.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ffdef5db9718e542bc9c7fecadbae6d"><gtr:id>1ffdef5db9718e542bc9c7fecadbae6d</gtr:id><gtr:otherNames>Comas I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>454164FE8EB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAEE3AC9-CFF7-48A8-ACEF-E8E06DE7F53B</gtr:id><gtr:title>Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ffdef5db9718e542bc9c7fecadbae6d"><gtr:id>1ffdef5db9718e542bc9c7fecadbae6d</gtr:id><gtr:otherNames>Comas I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_540e182e182b232a3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D114D0F-AB3A-48AA-B399-11A0E722B770</gtr:id><gtr:title>Strain classification of Mycobacterium tuberculosis: congruence between large sequence polymorphisms and spoligotypes.</gtr:title><gtr:parentPublicationTitle>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dcee8e73975ad36027a07504a4c43c42"><gtr:id>dcee8e73975ad36027a07504a4c43c42</gtr:id><gtr:otherNames>Kato-Maeda M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1027-3719</gtr:issn><gtr:outcomeId>XTMYvhVBsj4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>182A9D51-6785-407D-8E34-0ADF1CA7D2E2</gtr:id><gtr:title>High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76298fa0c29b9ef440eede30efaf9311"><gtr:id>76298fa0c29b9ef440eede30efaf9311</gtr:id><gtr:otherNames>Hershberg R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>4AD0254BA1F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB16958D-FBA8-4C2C-897C-ACCC9306849E</gtr:id><gtr:title>Genotyping of genetically monomorphic bacteria: DNA sequencing in Mycobacterium tuberculosis highlights the limitations of current methodologies.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ffdef5db9718e542bc9c7fecadbae6d"><gtr:id>1ffdef5db9718e542bc9c7fecadbae6d</gtr:id><gtr:otherNames>Comas I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>21ED428B314</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U117588500</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>